A Meta-Analysis of Association between Remdesivir and Mortality among Critically-Ill COVID-19 Patients.

ABSTRACT:

Background

The World Health Organization guidelines did not make a recommendation on use of remdesivir based on disease severity. Little is known regarding effectiveness of remdesivir in critically ill coronavirus disease 2019 (COVID-19) patients. This has led to a state of dilemma for doctors leaving them skeptical of whether they should continue to recommend the drug or not.

Materials and methods

A systematic search adhering to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines was conducted from inception until February 20, 2020. Electronic bibliographic databases (PubMed, Cochrane database, Scopus, Embase) were included. Using dichotomous data for select values, the unadjusted odds ratios (ORs) were calculated applying Mantel Haenszel

SUBMITTER: Razzack AA 

PROVIDER: S-EPMC8511372 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature